Ashina et al, Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial, Lancet Neurol 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5
Aurora et al, Cephalalgia. 2010 Jul;30(7):793-803. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Diener et al, Cephalalgia. 2010 Jul;30(7):804-14. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Jackson et al, PLoS One. 2019 Mar 20;14(3):e0212785 Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.
Jackson et al, J Gen Intern Med. 2017 Dec;32(12):1351-1358. Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.
Jackson et al, PLoS One. 2015 Jul 14;10(7):e0130733.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.
Kallen et al, Drug Saf, 2011 vol. 34(8) pp. 691-703 Delivery outcome after maternal use of drugs for migraine: a register study in Sweden
Liampas et al, Findings of systematic review and meta-analysis suggest potential benefit of melatonin in the prevention of migraine in adults Headache 2020 Apr 30
Nezvalova-Henriksen et al, Eur. J. Epidemiol., 2013 vol. 28(9) pp. 759-69 Triptan safety during pregnancy: a Norwegian population registry study
Stovner et al. Cephalalgia 2013; 34: 523–32. A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study.
Tepper et al, Lancet Neurol. 2017 Jun;16(6):425-434. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomi- sed, double-blind, placebo-controlled phase 2 trial.
Silberstein et al, N Engl J Med. 2017 Nov 30;377(22):2113-2122. Fremanezumab for the Preventive Treatment of Chronic Migraine.
